Search clinical trials for: 20% Reduced Dose Albumin

Total 244 results

Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis

Liver Cirrhosis | Spontaneous Bacterial Peritonitis

India
University Hospital, Linkoeping

Completed

Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects (VAB)

Burns

Sweden
Instituto Grifols, S.A.
Hospital Clinic of Barcelona

Completed

Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.

Cirrhosis | Ascites

Spain
Hospital de Clinicas de Porto Alegre

Unknown

Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study (ALTERNATE)

Renal Impairment | All Cause Mortality

Brazil
Instituto Grifols, S.A.
Grifols Biologicals, LLC

Completed

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)

Alzheimer's Disease

Spain, United States
EASL - CLIF Consortium

Terminated

The INFECIR-2 Albumin Prevention Study (INFECIR2)

Pneumonia | Cholangitis | Advanced Chronic Liver Disease | Urinary Infection | Other Bacterial Diseases

Spain
Jena University Hospital
German Research Foundation; Instituto Grifols, S.A.; University Hospital Goettingen and other collaborators

Recruiting

Albumin Replacement Therapy in Septic Shock (ARISS)

Septic Shock

Germany
University Hospital Inselspital, Berne

Completed

Impact of Hyperoncotic Albumin to Support Blood Loss Replacement (HYPALB)

Blood Loss, Surgical | Fluid Retention

Switzerland
Joachim Zdolsek

Recruiting

Fluid Challenge and Plasma Volume, During Surgery (FC-VE)

Gynecologic Cancer | Colorectal Cancer | Colorectal Disorders | Urologic Cancer | Benign Neoplasm

Sweden
Fifth Affiliated Hospital, Sun Yat-Sen University

Recruiting

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

Head and Neck Squamous Cell Carcinoma

China
Institute of Liver and Biliary Sciences, India

Completed

Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.

Spontaneous Bacterial Peritonitis

India
Rachael Cusack
Grifols Biologicals, LLC

Recruiting

Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock

Sepsis | Septic Shock | Sepsis, Severe

Ireland
Technical University of Munich

Completed

SUbstition of PERioperative Albumin Deficiency Disorders (SUPERADD)

Hypoalbuminemia

Germany
University Hospital Inselspital, Berne

Completed

Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement (VASCALB)

Blood Loss, Surgical | Fluid Retention

Switzerland
Leiden University Medical Center
Dutch Colorectal Cancer Group; Stichting Darmkanker

Not yet recruiting

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients With Metastatic Colorectal Cancer (DOSAGE)

Colorectal Cancer | Metastatic Cancer | Older Patients | Candidates for Palliative Chemotherapy

Netherlands
Govind Ballabh Pant Hospital

Suspended

Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis

Cirrhosis | Ascites

India
Taizhou Hospital
Taizhou Enze Medical Center (Group) Enze Hospital; Taizhou Cancer Hospital

Recruiting

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
University of Malaga

Completed

Specific Neurotechnical Strength Training (NeuroTraining)

Neuromuscular Adaptations

Spain
West China Hospital

Not yet recruiting

Optimal Reperfusion Strategy for STEMI Patients With Anticipated PPCI Delay

ST Elevation Myocardial Infarction
Indiana University

Completed

Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study (RADREMI)

Brain Cancer | Brain Tumor | Brain Metastases

United States
University Hospital, Strasbourg, France

Terminated

Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients (AlbAlsace)

Shock | Systemic Inflammatory Response Syndrome (SIRS) | Hypoalbuminaemia

France
Seoul St. Mary's Hospital
Green Cross Corporation

Terminated

The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke (ALbumin)

Cerebral Infarction

Korea, Republic of
Knopp Biosciences
Biogen

Completed

Dexpramipexole Japanese PK Study

Amyotrophic Lateral Sclerosis

United Kingdom
Maastricht University Medical Center

Terminated

Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)

Breast Neoplasm | Contrast-enhanced Spectral Mammography

Netherlands
University Hospital, Brest
University Hospital of Saint-Etienne

Completed

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. (RENOVE)

Venous Thromboembolism

France
Sodertalje Hospital
Karolinska University Hospital; University Hospital, Linkoeping

Unknown

Volume Kinetics for 20% Albumin in Different Clinical Situations (Albumin)

Inflammation | Unconscious

Sweden
Sheba Medical Center

Unknown

Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study

Carcinoma, Small Cell

Israel
UNICANCER

Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO (MOIO)

Melanoma | Renal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Lung Cancer Metastatic | Bladder Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma

France
Baylor College of Medicine

Recruiting

High Dose Albumin in Refractory Ascites

Ascites

United States
Icahn School of Medicine at Mount Sinai
Arizona State University; The Biodesign Institute

Active, not recruiting

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Squamous Cell Carcinomas

United States
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension

Liver Cirrhosis

India
Postgraduate Institute of Medical Education and...

Recruiting

20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotension

Acute-On-Chronic Liver Failure | Shock, Septic | Cirrhosis, Liver | Shock Hypovolemic

India
Ottawa Hospital Research Institute
The Physicians' Services Incorporated Foundation; The Kidney Foundation of... and other collaborators

Recruiting

Albumin To Enhance Recovery After Acute Kidney Injury (ALTER-AKI)

Critical Illness | Acute Kidney Injury | Hypotension | Renal Replacement Therapy

Canada
Washington University School of Medicine

Recruiting

Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

Astrocytoma | Glioma, Malignant | Oligodendroglioma, Adult

United States
Sunnybrook Health Sciences Centre

Recruiting

UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly (UNITED2)

Glioblastoma, IDH-mutant | Glioblastoma Multiforme, Adult

Canada
Leiden University Medical Center

Completed

Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines

Meningococcal Disease

Netherlands
Merck Sharp & Dohme LLC

Terminated

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)

DLBCL | AML Including AML de Novo and AML Secondary to MDS
Rambam Health Care Campus

Unknown

Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery

Elective Cardiac Surgery

Israel
University of Pennsylvania

Terminated

Reduced Radiation Dose and IR-impact on Coronary Calcium Quantification

Atherosclerotic Plaque

United States
Zhejiang Cancer Hospital

Unknown

Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer
Vanderbilt University Medical Center

Withdrawn

How Does Platelet Dose Impact Clinical Outcomes After PRP Treatment?

Osteoarthritis, Knee

United States
GlaxoSmithKline

Completed

Fosamprenavir in Pts With Hepatic Impairment

Infection, Human Immunodeficiency Virus
Brown University
Rhode Island Hospital; Memorial Hospital of Rhode Island; Lifespan

Completed

BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study (278)

Metastatic Pancreatic Cancer

United States
Washington University School of Medicine

Terminated

Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma

Lymphoma, Non-Hodgkin | Hodgkin Disease

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.

SARS-CoV-2

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.

SARS-CoV-2

China
Institute of Liver and Biliary Sciences, India

Completed

Comparison of Colloid (20% Albumin) Versus Crystalloid (Plasmalyte) for Fluid Resuscitation in Cirrhotics With Sepsis Induced Hypotension.

Cirrhosis With Sepsis

India
Shanxi Medical University

Not yet recruiting

The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

Hepatitis B Vaccine
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh; World Health... and other collaborators

Enrolling by invitation

Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine

Poliomyelitis

Bangladesh
Gazi University

Completed

Comparison of High Power Pain Threshold Ultrasound and Ischemic Compression Techniques for Treatment of Trigger Points

Trigger Point Pain, Myofascial

Turkey

Search clinical trials for: 20% Reduced Dose Albumin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations